Dias Cintia B, Amigó Núria, Wood Lisa G, Mallol Roger, Correig Xavier, Garg Manohar L
Nutraceuticals Research Group, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Metabolomics Platform, Rovira i Virgili University, IISPV, Avinguda Països Catalans 26, 43007 Tarragona, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), C/ Monforte de Lemos 3-5, 28029, Madrid, Spain; Biosfer Teslab, Plaça Prim 10, 2on 5a, 43201 Reus, Spain.
Metabolism. 2017 Mar;68:11-19. doi: 10.1016/j.metabol.2016.11.014. Epub 2016 Dec 1.
Dietary fat composition is known to modulate circulating lipid and lipoprotein levels. Although supplementation with long chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) has been shown to reduce plasma triglyceride levels, the effect of the interactions between LCn-3PUFA and the major dietary fats consumed has not been previously investigated.
In a randomized controlled parallel design clinical intervention, we examined the effect of diets rich in either saturated fatty acids (SFA) or omega-6 polyunsaturated fatty acids (n-6PUFA) on plasma lipid levels and lipoprotein profiles (lipoprotein size, concentration and distribution in subclasses) in subjects with an adequate omega 3 index. Twenty six healthy subjects went through a four-week pre-supplementation period with LCn-3PUFA and were then randomized to diets rich in either n-6PUFA or SFA both supplemented with LCn-3PUFA.
The diet rich in n-6PUFA decreased low density lipoprotein (LDL) particle concentration (-8%, p=0.013) and LDL cholesterol (LDL-C) level (-8%, p=0.021), while the saturated fat rich diet did not affect LDL particle concentration or LDL-C levels significantly. Nevertheless, dietary saturated fatty acids increased LCn-3PUFA in plasma and tissue lipids compared with n-6PUFA, potentially reducing other cardiovascular risk factors such as inflammation and clotting tendency.
Improvement on the omega 3 index of healthy subjects did not alter the known effects of dietary saturated fats and n-6PUFA on LDL profiles.
已知膳食脂肪组成可调节循环脂质和脂蛋白水平。尽管补充长链ω-3多不饱和脂肪酸(LCn-3PUFA)已被证明可降低血浆甘油三酯水平,但此前尚未研究LCn-3PUFA与所摄入的主要膳食脂肪之间相互作用的影响。
在一项随机对照平行设计的临床干预中,我们研究了富含饱和脂肪酸(SFA)或ω-6多不饱和脂肪酸(n-6PUFA)的饮食对ω-3指数充足的受试者血浆脂质水平和脂蛋白谱(脂蛋白大小、浓度及亚类分布)的影响。26名健康受试者在补充LCn-3PUFA的情况下经历了为期四周的预补充期,然后被随机分配到富含n-6PUFA或SFA且均补充了LCn-3PUFA的饮食组。
富含n-6PUFA的饮食降低了低密度脂蛋白(LDL)颗粒浓度(-8%,p=0.013)和LDL胆固醇(LDL-C)水平(-8%,p=0.021),而富含饱和脂肪的饮食对LDL颗粒浓度或LDL-C水平无显著影响。然而,与n-6PUFA相比,膳食饱和脂肪酸增加了血浆和组织脂质中的LCn-3PUFA,可能降低了其他心血管危险因素,如炎症和凝血倾向。
健康受试者ω-3指数的改善并未改变膳食饱和脂肪和n-6PUFA对LDL谱的已知影响。